Alytmedis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 312,210 | 261,992 | 37,535 | 288,618 | 34,700 | 23,699 | 14,790 | 35,134 |
| Profit before tax | 93,531 | - | - | - | - | - | -1,787 | 23,207 |
| Net profit | 82,955 | 167,585 | 5,608 | 69,110 | 21,041 | 19,453 | -1,883 | 21,815 |
| Equity | 94,396 | 261,981 | 267,589 | 336,699 | 357,395 | 397,846 | 395,963 | 417,778 |
| Liabilities | 169,885 | 13,855 | 14,414 | 36,581 | 34,841 | 25,734 | 159,113 | 142,926 |
| Non-current assets | 56,265 | 60,291 | 58,179 | 47,669 | 46,619 | 83,997 | 445,097 | 444,112 |
| Current assets | 208,016 | 215,545 | 223,824 | 325,611 | 345,617 | 339,583 | 109,979 | 116,592 |
| Total assets | 264,281 | 275,836 | 282,003 | 373,280 | 392,236 | 423,580 | 555,076 | 560,704 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 589 | 1,282 | 2,706 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -10.8% | -16.1% | -85.7% | +668.9% | -88.0% | -31.7% | -37.6% | +137.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 31.4% | 60.8% | 2.0% | 18.5% | 5.4% | 4.6% | -0.3% | 3.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 87.9% | 64.0% | 2.1% | 20.5% | 5.9% | 4.9% | -0.5% | 5.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 26.6% | 64.0% | 14.9% | 23.9% | 60.6% | 82.1% | -12.7% | 62.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 30.0% | - | - | - | - | - | -12.1% | 66.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.8 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 144,095 | 174,661 | 37,535 | 288,618 | 20,820 | 11,850 | 7,395 | 35,134 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Alytmedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-12-18 | 2024-01-02 | 7.17 |
| 2022-10-31 | 2022-11-14 | 43.86 |
| 2022-10-18 | 2022-10-30 | 43.50 |
| 2022-09-16 | 2022-09-22 | 56.73 |
| 2022-08-23 | 2022-09-15 | 9.83 |
| 2022-07-25 | 2022-08-02 | 9.83 |
| 2022-07-21 | 2022-07-24 | 9.66 |
| 2022-07-18 | 2022-07-20 | 56.56 |
| 2022-06-16 | 2022-07-17 | 9.66 |
| 2022-04-19 | 2022-05-10 | 10.00 |
| 2022-02-17 | 2022-03-13 | 0.01 |
| 2022-01-18 | 2022-01-31 | 0.01 |
| 2021-12-16 | 2022-01-16 | 0.01 |
| 2021-09-16 | 2021-10-03 | 0.01 |
Alytmedis - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Alytmedis is: 2 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 1.55 |
| 2026-08-31 | 2026-08-31 | 1.35 |
| 2026-07-23 | 2026-08-30 | 1.03 |
| 2026-07-02 | 2026-07-22 | 0.54 |
| 2026-06-19 | 2026-07-01 | 81.91 |
| 2026-01-31 | 2026-02-16 | 0.54 |
| 2026-01-17 | 2026-01-30 | 0.52 |
| 2025-12-17 | 2025-12-17 | 0.52 |
| 2025-10-02 | 2025-10-18 | 1.28 |
| 2025-09-16 | 2025-10-01 | 1.14 |
| 2025-09-09 | 2025-09-15 | 21.33 |
| 2025-09-08 | 2025-09-08 | 261.33 |
| 2025-09-05 | 2025-09-07 | 261.19 |
| 2025-09-01 | 2025-09-04 | 960.19 |
| 2025-08-31 | 2025-08-31 | 952.36 |
| 2025-08-27 | 2025-08-30 | 952.02 |
| 2025-03-20 | 2025-03-20 | 505.01 |
| 2025-02-20 | 2025-03-19 | 1.73 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Alytmedis, UAB (code 303833356) is a Private Limited Liability Company operating in support services to forestry. In 2025, the company generated €35.1K in revenue, up 137.6% year on year and 48.2% over two years, and returned to profit with net income of €21.8K. This followed a weaker 2024, when revenue fell to €14.8K and the company posted a net loss of €1.9K after a profitable 2023, when revenue was €23.7K and net profit reached €19.5K. Profitability improved materially in 2025, with a net margin of 62.1%. The balance sheet remained solid, with total assets of €560.7K, equity of €417.8K and liabilities of €142.9K at the end of 2025. Long-term assets accounted for €444.1K, while short-term assets were €116.6K. Key ratios for 2025 show an equity ratio of 74.5%, debt-to-equity of 0.34, ROE of 5.2%, ROA of 3.9% and asset turnover of 0.06x. Revenue per employee stood at €35.1K, matching the reported latest-year productivity measure.